Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Older people at home often have skin issues, but there's little evidence on how to prevent or treat them effectively.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

A man's unusual scalp folds caused by a skin condition were treated with surgery and remained unchanged two years later.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Hair follicle-derived sheets can effectively treat vitiligo by repigmenting skin.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hair follicle stem cells could be used to treat the skin condition vitiligo.

High TNF-α levels may increase hair loss risk after PRP therapy.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Researchers successfully grew horse skin cells that produce pigment from hair follicle samples.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Dermoscopy helps doctors recognize a type of benign skin tumor called pilomatricoma.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

A new mouse model effectively mimics vitiligo for research and drug testing.

Hair follicles are vital for skin health, cancer prevention, and wound healing.